郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.

期刊：Pulmonary pharmacology & therapeutics发表年份：2015作者：A Planagumà; T Domènech; M Pont; E Calama; V García-González; R López; M Aulí; M López; S Fonquerna; I Ramos; J de Alba; A Nueda; N Prats; V Segarra; M Miralpeix; M D Lehner
阅读更多 →

药效评价Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide.

期刊：European journal of pharmacology发表年份：2015作者：Kazune Arai; Aki Kashiwazaki; Yoko Fujiwara; Hiroyoshi Tsuchiya; Nobuya Sakai; Katsushi Shibata; Taka-aki Koshimizu
阅读更多 →

药效评价Pharmacological characterization of the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) as a potent NCX3 inhibitor that worsens anoxic injury in cortical neurons, organotypic hippocampal cultures, and ischemic brai

期刊：ACS chemical neuroscience发表年份：2015作者：Agnese Secondo; Giuseppe Pignataro; Paolo Ambrosino; Anna Pannaccione; Pasquale Molinaro; Francesca Boscia; Maria Cantile; Ornella Cuomo; Alba Esposito; Maria Josè Sisalli; Antonella Scorziello; Natascia Guida; Serenella Anzilotti; Ferdinando Fiorino
阅读更多 →

药效评价A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression.

期刊：Organic & biomolecular chemistry发表年份：2015作者：Xuyi Yue; Hongjun Jin; Hui Liu; Adam J Rosenberg; Robyn S Klein; Zhude Tu
阅读更多 →